Search Results 11-20 of 16362 for Aspergillosis
Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA ...
For treatment of invasive aspergillosis: For oral dosage form (delayed-release tablets):. Adults and children 13 years of age and older—300 milligrams (mg) ...
... aspergillosis, IA). Participation eligibility. Participant eligibility ... aspergillosis. 4. Suspected mucormycosis (zygomycosis). 5. Patients with a ...
... aspergillosis (IA) caused by a non-fumigatus species. A Study to Evaluate Interferon-gamma in Antifungal Immunity Rochester, MN. The purpose of this study is ...
... aspergillosis. Safety and efficacy have been established. Geriatric. Appropriate studies performed to date have not demonstrated geriatric-specific problems ...
Paschalis Vergidis, M.D., investigates the epidemiology, diagnosis and treatment of fungal infections such as candidiasis, aspergillosis and endemic mycoses ...
... aspergillosis (fungal infection in the lungs). It is also used to treat fungal infections assumed to be present in patients with febrile neutropenia ...
Voriconazole injection is used to treat certain serious fungal or yeast infections, such as aspergillosis (fungal infection in the lungs), candidemia ...
Allergic bronchopulmonary aspergillosis. This reaction to fungus in the lungs can occur in people with asthma or cystic fibrosis. Hypersensitivity ...
Isavuconazonium injection is used to treat serious fungal or yeast infections, including invasive aspergillosis and invasive mucormycosis. This medicine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.